Nanomedicine is a multidisciplinary field merging nanotechnology with
medicine to address complicated health challenges at the cellular and molecular levels.
The fundamental theory involves operating with materials at the nanoscale (1-100
nanometers), where distinctive physical, chemical, and biological characteristics
become apparent. These nanoscale substances can interact with cellular systems in
novel ways, allowing precise diagnostics, selective drug delivery, and novel therapeutic
methods. Key developments include the progress of nanoparticle-derived delivery
systems that enhance the bioavailability and singularity of treatments, decreasing side
effects. Nanobiomedicine also plays a crucial role in evaluation and diagnostics, where
nanosensors and imaging agents enable the early detection of diseases, including
cancer and other infectious diseases. Additionally, nanotechnology has potential in
regenerative medicine and tissue engineering, where nanomaterials help in tissue repair
and cell growth. Recent advancements, for instance, the incorporation of nanorobots
for minimum invasive processes and the utilization of biocompatible nanostructures for
customized medications, highlight the revolutionary potential of nanobiomedicine.
Although challenges like ethical concerns, toxicity, and regulatory obstacles must be
recognised for widespread clinical application, with continuous research,
nanobiomedicine promises to transform healthcare, providing more potent,
personalized, and reduced invasive medical solutions.
Keywords: Cancer therapy, Diagnostic imaging , Nanomedicine , Nanoparticles, Regenerative medicines, Targeted drug delivery.
